<?xml version="1.0" encoding="UTF-8"?>
<p>In light of these successful developments, a human WNV vaccine should already be on the market or at least in the final phases of clinical testing. But in contrast, none of the clinical studies proceeded after stage II, most strategies have stopped already several years ago.
 <sup>
  <xref rid="CIT0030">30</xref>
 </sup> Today, there is still no human WNV vaccine, and there is no candidate even close to licensure. Current prevention strategies rely mainly on mosquito control programs.
 <sup>
  <xref rid="CIT0031">31</xref>
 </sup> Although these are much cheaper than vaccines, which require long and expensive clinical developments, their effects are transient. Immunization would clearly be a sustainable, long-lasting method to protect humans from disease caused by WNV.
</p>
